Several studies using [177Lu]Lu-PSMA-617 and [177Lu]Lu-PSMA-I&T as a therapy have shown to be very effective in treating PCa [7,8,9,10,11,12,13,14,15,16], while at the same time being well tolerated, with minor side effects. Here, FOLH1 is linked to posterior cortical atrophy.